Why Choose Us?

 Our Commitment to Patients

When patients come to the Colorado Blood Cancer Institute, the entire treatment team is committed to ensuring their comfort and safety. We understand that it can be difficult for many of our patients who leave their communities and come to an unfamilar place for specialized care.

We have staff that will assist with housing needs, financial assistance, as well as resources for caregivers. We also offer a variety of support groups, and our team works closely with referring physicians to make sure they are kept up-to-date on patients’ progress. As a convenience to our patients, our physicians provide services to an extended geographical area by traveling routinely to partner clinics in Montana, New Mexico, Wyoming and Colorado. The close collaboration between CBCI specialists and physicians in outreach areas allows patients to remain in their communities for follow up care.

This diagram demonstrates the 5 year survival of patients diagnosed and treated at the Colorado Blood Cancer Institute (CBCI)/Presbyterian St. Luke’s (PSL) Medical Center versus the state of Colorado and across the nation. The results reveal an improved survival for AML patients at CBCI.

 AML Survival 2003-2006

“Since these results reflect the care of patients who were diagnosed between 7 and 10 years ago, one should not  focus on the actual survival rates but just on the comparisons. Of course, with the approval of so many new drugs since 2000 for myeloma (thalidomide, Velcade, Doxil, Revlimid, carfilzomib and pomalidomide) survival rates have increased dramatically since then. We believe these data reflect specific expertise in treating myeloma and other blood cancers. Myeloma is a specialty of ours at CBCI and we have at our disposal the range of important treatments including stem cell transplantation and novel research treatment

 Myeloma Survival


Psychosocial Oncology

While the cancer experience is physical in nature, it is also an emotional experience for patients and their loved ones. Cancer gives rise to a number of psychological and social problems that, when not addressed can lead to increased distress. As a commitment to providing the highest quality cancer care, the Presbyterian/St. Luke’s Comprehensive Cancer Program has developed a new department, the Psychosocial Oncology Department, to better meet the psychosocial needs of cancer patients.

The Department Director, Teri Simoneau, Ph.D., is a nationally recognized psychologist who is involved in research related to “chemo brain” and care giver stress. The department also includes a well-established psychology postdoctoral training program and a new practicum training program for graduate students in clinical psychology.

Accreditations, Program Memberships and Collaborations

  • American Society for Blood and Marrow Transplantation
  • Center for International Blood and Marrow Transplant Research
  • The Foundation for the Accreditation of Cellular Therapy (FACT)
  • Colorado Cancer Research Program
  • National Donor Marrow Program